Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
van, den, Boom, L; Ziko, H; Mader, JK, ;on behalf of the Hypo-RESOLVE, Consortium;AiDAPT, AP@home04, CLOuD, DAN05, DAN06, and, KidsAP, consortia;HYPO-RESOLVE, Consortium;KidsAP, Consortium.
Safely finishing a half marathon by an adult with type 1 diabetes using a commercially available hybrid closed-loop system.
J Diabetes Investig. 2021; 12(3):450-453
Doi: 10.1111/jdi.13356
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Mader Julia
- Ziko Haris
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Glycemic targets are often difficult to achieve in people with type 1 diabetes, especially during exercise. Consequently, many people with type 1 diabetes avoid sports as a result of fear of hypoglycemia. Strenuous physical activity, such as a half marathon, imposes difficulties on people with type 1 diabetes. The first commercial hybrid closed-loop (HCL) system with the potential to facilitate better diabetes management during exercise has recently been marketed. So far, no data on HCL performance during strenuous exercise have been published. A woman with well-controlled type 1 diabetes participated in and safely finished a half marathon while undergoing HCL therapy. HCL could safely establish glycemic control without causing either hypo- or relevant hyperglycemia, and without the need for rescue carbohydrates while running. In the days after the half marathon, there was no change in glycemic control compared with the period before.
- Find related publications in this database (Keywords)
- Half marathon
- Hybrid closed-loop system
- Type 1 diabetes